2026年5月期 第3四半期決算説明資料

This document is the financial results presentation for the third quarter of the fiscal year ending May 2026, announced on April 14, 2026. The revenue reached 4,950 million yen, marking a 12.0% increase compared to the same period last year. Operating profit was 121 million yen, and net profit attributable to shareholders was 125 million yen. The domestic dental trading business performed well, and the medical BtoB sector turned profitable. The absence of losses from the previously excluded company, Miruteru, contributed to the profit increase. Future strategies include strengthening the brand and expanding promotions.